论文部分内容阅读
本文报告HAP-DOM方案治疗急性非淋巴细胞白血病13例,CR10例(76.9%)。本方案毒性反应较轻。
This article reports HAP-DOM regimen in the treatment of acute non-lymphocytic leukemia in 13 cases, CR10 cases (76.9%). The program toxicity less.